NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

nonsensical speculation and incorrect restatement of my prior post

Here we go. I'll try to use small words to explain this to you.

What I said was correct. You don't understand what you posted as an example.

You used Novan as a comparator to demonstrate why it is good for Northwest to sit on data. Your claim was that Novan released TLD when their price was around $4.50, the price spiked to $11, but because it is taking a long time to get to a publication the price is depreciating and is now back to its pre-TLD levels. Here are your own quotes to prove this is true, and a link to your message that you wrote.

427102

NOVN. Released TLD ($11 sp)

...there was a long delay before publication

the stock price has tanked below the price prior to TLD ($4.5).

So, if you use this comparison with NWBO, here is what the exact same scenario happening looks like for Northwest. I'm literally just going to replace "NOVN" with "NWBO", and replace the NOVN price with the corresponding NWBO price. Same ratios and all. Apples to apples, can't get any simpler than this.

NWBO. Released TLD ($4.88 sp)

...there was a long delay before publication

the stock price has tanked below the price prior to TLD ($2).

So, had we taken this route, the NOVN route that you cited, we'd be sitting at ~$2 waiting for publication. Versus where we are actually at, which is $0.60. I can do some more math to show you which one of these numbers is better, but I think you've got it from here.